MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
3355.64%
Quick Ratio
3355.64%
Cash Ratio
1313.68%
Debt to Asset Ratio
3.06%
Unit: Dollar
Assets Breakdown
    • Investments
    • Cash and cash equivalents
    • Other current assets
    • Operating lease right-of-use ass...
Liabilities Breakdown
    • Additional paid-in capital
    • Retained earnings (accumulated d...
    • Accounts payable, accrued expens...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
52,757,766
52,544,263
127,677,360
39,501,936
Investments
81,541,216
84,948,677
15,998,427
13,748,473
Other current assets
464,727
250,903
414,825
497,294
Total current assets
134,763,709
137,743,843
144,090,612
53,747,703
Operating lease right-of-use asset
215,120
239,882
106,666
118,170
Total assets
134,978,829
137,983,725
144,197,278
53,865,873
Accounts payable, accrued expenses and other current liabilities
4,016,031
2,457,748
2,568,549
1,583,613
In-process r and d accrued expenses
-
-
0
0
Total current liabilities
4,016,031
2,457,748
2,568,549
1,583,613
Operating lease liability - non-current
107,829
131,565
70,881
80,366
Total liabilities
4,123,859
2,589,313
2,639,430
1,663,979
Common stock, par value of 0.001 per share, 40,000,000 shares authorized, 6,712,172 and 6,692,140 shares issued and outstanding at june 30, 2026, and december 31, 2025, respectively
6,712
6,699
6,663
6,127
Additional paid-in capital
229,472,821
228,691,772
225,848,222
132,989,324
Accumulated other comprehensive income (loss)
91,317
98,521
11,698
77,577
Retained earnings (accumulated deficit)
-98,715,880
-93,402,580
-84,308,735
-80,871,134
Total stockholders equity
130,854,970
135,394,412
141,557,848
52,201,894
Total liabilities and stockholders equity
134,978,829
137,983,725
144,197,278
53,865,873
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Investments$81,541,216 (493.09%↑ Y/Y)Cash and cashequivalents$52,757,766 (33.56%↑ Y/Y)Other current assets$464,727 (-6.55%↓ Y/Y)Total current assets$134,763,709 (150.73%↑ Y/Y)Operating leaseright-of-use asset$215,120 (82.04%↑ Y/Y)Total assets$134,978,829 (150.58%↑ Y/Y)Total liabilities andstockholders equity$134,978,829 (150.58%↑ Y/Y)Total stockholdersequity$130,854,970 (150.67%↑ Y/Y)Total liabilities$4,123,859 (147.83%↑ Y/Y)Retained earnings(accumulated deficit)-$98,715,880 (-22.07%↓ Y/Y)Additional paid-in capital$229,472,821 (72.55%↑ Y/Y)Total currentliabilities$4,016,031 (153.60%↑ Y/Y)Operating lease liability- non-current$107,829 (34.17%↑ Y/Y)Accumulated othercomprehensive income (loss)$91,317 (17.71%↑ Y/Y)Common stock, par valueof 0.001 per share,...$6,712 (9.55%↑ Y/Y)Accounts payable,accrued expenses and...$4,016,031 (153.60%↑ Y/Y)

Monopar Therapeutics (MNPR)

Monopar Therapeutics (MNPR)